Veterinary Medicines

Nafpenzal DC Intramammary Suspension

Not authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium
Download as PDF

Product identification

Medicine name:
Nafpenzal DC Intramammary Suspension
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Dihydrostreptomycin sulfate
    116.81
    milligram(s)
    /
    1.00
    Syringe
  • Nafcillin sodium
    105.31
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        48
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
This information is not available for this product.
Package description:
  • Each 3 g syringe is made of low density polyethylene. The syringes are packed in a sachet. The sachet is packed in a carton. Cleaning towels packed in a sachet are also included in the carton. Packs of 20 syringes and 20 cleaning towels.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/074/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."